-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RSC-1255 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RSC-1255 in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SLN-124 in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SLN-124 in Alpha Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SLN-124 in Alpha ThalassaemiaDrug Details: SLN-124 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Simurosertib in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Simurosertib in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Simurosertib in Metastatic Colorectal Cancer Drug Details:TAK-931 is under development for the...
-
Product Insights
TAZIZ Ruwais Complex, United Arab Emirates
TAZIZ Ruwais Complex is proposed to be built in Abu Dhabi, United Arab Emirates. It is expected to come online in 2025. Empower your strategies with our TAZIZ Ruwais Complex, United Arab Emirates report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RSC-1255
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RSC-1255 Drug Details RSC-1255 is under development for the treatment of advanced solid tumor...